Glucose intolerance in children with cystic fibrosis: a developing country's perspective. 2018

Lakshmipathi Naik Banavath, and Rakesh Kumar, and Devi Dayal, and Jaivinder Yadav, and Naresh Sachdeva, and Joseph L Mathew, and Pankaj C Vaidya, and Meenu Singh
Pediatric Endocrinology and Diabetes Division, Postgraduate Institute of Medical Education and Research (PGIMER), Sector 12, Chandigarh, India.

Background Cystic fibrosis-related diabetes (CFRD) is a common comorbidity reported in patients with cystic fibrosis (CF). There is a dearth of data on glucose intolerance or CFRD in children with CF from developing countries. So, we planned to study the prevalence of abnormal glucose tolerance (AGT) in children with CF and its relation with the duration and severity of CF. Methods We performed an oral glucose tolerance test (OGTT) on children (2-18 years old) having CF for at least 6 months. Two-hour plasma glucose levels on OGTT were correlated with various disease-related factors. Results Out of the 25 children enrolled, there were 18 boys and seven girls. The mean age and duration of CF were 7.9±4.3 and 3.16±2.5 years, respectively. AGT was observed in 16 (64%) children with CF including three (12%) children with CFRD. Children with a duration of CF of 3 years had significantly higher prevalence (81.8%) of AGT when compared with duration ≤3 years (p-value<0.05). Twelve out of 17 (70.6%) children were colonized with Pseudomonas and 12 out of 15 (80%) children >6 years of age had AGT. There was a positive correlation of 2-h glucose value on OGTT with duration of CF and number of hospitalizations with acute pulmonary exacerbations. Conclusions The majority of children having CF for >3 years and/or age >6 years developed AGT. In our clinical setting, an annual screening with OGTT to detect AGT may be required at an early age and duration of CF.

UI MeSH Term Description Entries
D007194 India A country in southern Asia, bordering the Arabian Sea and the Bay of Bengal, between Burma and Pakistan. The capitol is New Delhi. Republic of India
D008297 Male Males
D008403 Mass Screening Organized periodic procedures performed on large groups of people for the purpose of detecting disease. Screening,Mass Screenings,Screening, Mass,Screenings,Screenings, Mass
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003550 Cystic Fibrosis An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION. Mucoviscidosis,Cystic Fibrosis of Pancreas,Fibrocystic Disease of Pancreas,Pancreatic Cystic Fibrosis,Pulmonary Cystic Fibrosis,Cystic Fibrosis, Pancreatic,Cystic Fibrosis, Pulmonary,Fibrosis, Cystic,Pancreas Fibrocystic Disease,Pancreas Fibrocystic Diseases
D005260 Female Females
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Lakshmipathi Naik Banavath, and Rakesh Kumar, and Devi Dayal, and Jaivinder Yadav, and Naresh Sachdeva, and Joseph L Mathew, and Pankaj C Vaidya, and Meenu Singh
February 2003, The Journal of pediatrics,
Lakshmipathi Naik Banavath, and Rakesh Kumar, and Devi Dayal, and Jaivinder Yadav, and Naresh Sachdeva, and Joseph L Mathew, and Pankaj C Vaidya, and Meenu Singh
August 1969, The New England journal of medicine,
Lakshmipathi Naik Banavath, and Rakesh Kumar, and Devi Dayal, and Jaivinder Yadav, and Naresh Sachdeva, and Joseph L Mathew, and Pankaj C Vaidya, and Meenu Singh
May 1989, Archives of disease in childhood,
Lakshmipathi Naik Banavath, and Rakesh Kumar, and Devi Dayal, and Jaivinder Yadav, and Naresh Sachdeva, and Joseph L Mathew, and Pankaj C Vaidya, and Meenu Singh
February 1997, Danish medical bulletin,
Lakshmipathi Naik Banavath, and Rakesh Kumar, and Devi Dayal, and Jaivinder Yadav, and Naresh Sachdeva, and Joseph L Mathew, and Pankaj C Vaidya, and Meenu Singh
September 2001, Paediatric respiratory reviews,
Lakshmipathi Naik Banavath, and Rakesh Kumar, and Devi Dayal, and Jaivinder Yadav, and Naresh Sachdeva, and Joseph L Mathew, and Pankaj C Vaidya, and Meenu Singh
November 2010, Pediatric diabetes,
Lakshmipathi Naik Banavath, and Rakesh Kumar, and Devi Dayal, and Jaivinder Yadav, and Naresh Sachdeva, and Joseph L Mathew, and Pankaj C Vaidya, and Meenu Singh
June 2009, Diabetic medicine : a journal of the British Diabetic Association,
Lakshmipathi Naik Banavath, and Rakesh Kumar, and Devi Dayal, and Jaivinder Yadav, and Naresh Sachdeva, and Joseph L Mathew, and Pankaj C Vaidya, and Meenu Singh
February 1970, The New England journal of medicine,
Lakshmipathi Naik Banavath, and Rakesh Kumar, and Devi Dayal, and Jaivinder Yadav, and Naresh Sachdeva, and Joseph L Mathew, and Pankaj C Vaidya, and Meenu Singh
January 1974, Clinical pediatrics,
Lakshmipathi Naik Banavath, and Rakesh Kumar, and Devi Dayal, and Jaivinder Yadav, and Naresh Sachdeva, and Joseph L Mathew, and Pankaj C Vaidya, and Meenu Singh
January 2015, Developmental period medicine,
Copied contents to your clipboard!